未知生产厂商
Platelet-rich plasma (PRP) is an autologous orthobiological product derived from a patient's own blood. It belongs to a family of orthobiological compounds that have been proven with high levels of evidence to be safe and effective for supporting healing. PRP has been studied since at least 2007, requiring nearly two decades of research vigilance to understand its role in muscle, tendon, and joint healing. It is allowed by the FDA and is not prohibited by athletic governing bodies.
Platelet-rich plasma (PRP) is an autologous orthobiological product derived from a patient's own blood. It belongs to a family of orthobiological compounds that have been proven with high levels of evidence to be safe and effective for supporting healing. PRP has been studied since at least 2007, requiring nearly two decades of research vigilance to understand its role in muscle, tendon, and joint healing. It is allowed by the FDA and is not prohibited by athletic governing bodies.
共 3 项相关疾病
每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。
显示相关度最高的 100 个专利族。
